Expert opinions on immunotherapy for patients with colorectal cancer-Reference-Cited by-同舟云学术

Expert opinions on immunotherapy for patients with colorectal cancer

Published:2020-09-18 Issue:10 Volume:40 Page:467-472
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Wang Feng¹,Wang Zi‐Xian¹,Chen Gong²,Luo Hui‐Yan¹,Zhang Dong‐Sheng¹,Qiu Miao‐Zhen¹^ORCID,Wang De‐Shen¹,Pan Zhi‐Zhong²,Shen Lin³,Li Jin⁴,Zhang Su‐Zhan⁵,Xu Rui‐Hua¹^ORCID

Affiliation:

1. Department of Medical Oncology Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou Guangdong 510060 P. R. China

2. Department of Colorectal Surgery Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou 510060 P. R. China

3. Department of Gastrointestinal Medical Oncology Peking University Cancer Hospital Beijing 100142 P. R. China

4. Department of Medical Oncology Tongji University Shanghai East Hospital Shanghai 200120 P. R. China

5. Department of Surgical Oncology The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang 310009 P. R. China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12095

Reference28 articles.

1. Immunotherapy in colorectal cancer: rationale, challenges and potential

2. Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer